Paper · 42650737
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 25
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32117132 | Resistance Evolution Against Antimicrobial Peptides in Staphylococcus aureus Alters Pharmacodynamics Beyond the MIC. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32117132 | PubMed |
| 2 | 36980322 | Antibiotic Resistance Diagnosis in ESKAPE Pathogens-A Review on Proteomic Perspective. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/36980322 | PubMed |
| 3 | 35065702 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. | Lancet | 2022 | https://conductscience.org/library/papers/35065702 | PubMed |
| 4 | 31191496 | YhjX Regulates the Growth of Escherichia coli in the Presence of a Subinhibitory Concentration of Gentamicin and Mediates the Adaptive Resistance to Gentamicin. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31191496 | PubMed |
| 5 | 31385762 | Antiviral Activities of Human Host Defense Peptides. | Curr Med Chem | 2020 | https://conductscience.org/library/papers/31385762 | PubMed |
| 6 | 34684258 | Bacterial Antibiotic Resistance: The Most Critical Pathogens. | Pathogens | 2021 | https://conductscience.org/library/papers/34684258 | PubMed |
| 7 | 39475864 | In vitro antibacterial activity of Morinda citrifolia extracts against eight pathogenic bacteria species. | PLoS One | 2024 | https://conductscience.org/library/papers/39475864 | PubMed |
| 8 | 21793988 | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. | Clin Microbiol Infect | 2012 | https://conductscience.org/library/papers/21793988 | PubMed |
| 9 | 11168187 | EUCAST Definitive Document E.DEF 3.1, June 2000: Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. | Clin Microbiol Infect | 2000 | https://conductscience.org/library/papers/11168187 | PubMed |
| 10 | 40118976 | Antimicrobial activity of cephamycins and β-lactam/β-lactamase inhibitors against ESBL-producing Escherichia coli and Klebsiella pneumoniae under standard and high bacterial inocula. | Sci Rep | 2025 | https://conductscience.org/library/papers/40118976 | PubMed |
| 11 | 40260375 | Global trends in antimicrobial resistance of Enterococcus faecium: a systematic review and meta-analysis of clinical isolates. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40260375 | PubMed |
| 12 | 32257965 | Antifungal Peptides as Therapeutic Agents. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32257965 | PubMed |
| 13 | 22421877 | Modulating immunity as a therapy for bacterial infections. | Nat Rev Microbiol | 2012 | https://conductscience.org/library/papers/22421877 | PubMed |
| 14 | 31941022 | Development and Challenges of Antimicrobial Peptides for Therapeutic Applications. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/31941022 | PubMed |
| 15 | 28273381 | Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence. | Pharmacotherapy | 2017 | https://conductscience.org/library/papers/28273381 | PubMed |
| 16 | 39254296 | Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant Klebsiella pneumoniae: an in vitro and in vivo analysis. | Antimicrob Agents Chemother | 2024 | https://conductscience.org/library/papers/39254296 | PubMed |
| 17 | 36290075 | Antimicrobial Peptides-Mechanisms of Action, Antimicrobial Effects and Clinical Applications. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36290075 | PubMed |
| 18 | 39894233 | Novel antibacterial agents and emerging therapies in the fight against multidrug-resistant Acinetobacter baumannii. | Microb Pathog | 2025 | https://conductscience.org/library/papers/39894233 | PubMed |
| 19 | 33106260 | Systematic Investigation of Resistance Evolution to Common Antibiotics Reveals Conserved Collateral Responses across Common Human Pathogens. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/33106260 | PubMed |
| 20 | 21573784 | Multifunctional cationic host defence peptides and their clinical applications. | Cell Mol Life Sci | 2011 | https://conductscience.org/library/papers/21573784 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/42650737/references